Pharma - HealthQuill

DIOSynVax, a spin-out company of the University of Cambridge, is in its final stage of human trials of an antigen-based vaccine candidate to treat all coronaviruses.

DIOSynVax to finish coronavirus vaccine trial in humans by month-end

HQ Team September 29, 2023: DIOSynVax, a spin-out company of the University of Cambridge, is in its final stage of human trials of.

by HealthQuill
September 29, 2023
0 Comments

The USFDA has issued civil money penalties to 22 retailers selling illegal e-cigarettes and sought up to a maximum of $19,192 fine for a single violation from each retailer.

Drugs Health Pharma

USFDA imposes maximum fine on 22 retailers for selling illegal e-cigarettes

HQ Team September 29, 2023: The USFDA has issued civil money penalties to 22 retailers selling illegal e-cigarettes and sought up to a.

by HealthQuill
September 29, 2023
0 Comments

Merck’s Biological Licence Application for a pulmonary arterial hypertension drug has been accepted for a priority review by the FDA.

Drugs Health Pharma

Merck gets priority review nod from USFDA for hypertension drug

HQ Team September 28, 2023: Merck’s Biological Licence Application for a pulmonary arterial hypertension drug has been accepted for a priority review by.

by HealthQuill
September 28, 2023
0 Comments

US scientists have honed in on a single chimeric antigen receptor T-cell (CAR T) therapy to cure all forms of blood cancer.

Drugs Health Pharma

US scientists zero in on single blood cancer therapy in animal studies

HQ Team September 28, 2023: US scientists have honed in on a single chimeric antigen receptor T-cell (CAR T) therapy to cure all.

by HealthQuill
September 28, 2023
0 Comments

Swiss biotechnology company, Basilea Pharmaceutica’s last stage trials of ceftobiprole to treat bacterial bloodstream infections have shown favourable outcomes, according to a statement.

Drugs Health Pharma

Swiss firm Basilea reports positive results in late-stage Staph trials

HQ Team September 28, 2023: Swiss biotechnology company, Basilea Pharmaceutica’s last stage trials of ceftobiprole to treat bacterial bloodstream infections have shown favourable.

by HealthQuill
September 28, 2023
0 Comments

Using structural and mechanistic information of two parasitic proteins, scientists have built a new component for a vaccine that may induce an immune response to malaria.

Drugs Health Pharma

NIAD develops protein that may help build new malaria vaccine

HQ Team September 28, 2023: Using structural and mechanistic information of two parasitic proteins, scientists have built a new component for a vaccine.

by HealthQuill
September 28, 2023
0 Comments

Earthworms help produce 140 MMT of food a year — about the amount of cereal grains grown by the world’s fourth largest producer Russia annually, a study finds.

Climate Health Pharma

Earthworms bestow 6.5% of global grain yield: US study finds

HQ Team September 27, 2023: Earthworms help produce 140 MMT of food a year — about the amount of cereal grains grown by.

by HealthQuill
September 27, 2023
0 Comments

Thirty-three governments got dragged to the Strasbourg Court by six Portugal adolescents, who argued the states were acting slowly against climate change.

Climate Health Pharma

Strasbourg Court begins hearing on climate charges against 33 nations

HQ Team September 27, 2023: Thirty-three governments got dragged to the Strasbourg Court by six Portugal adolescents, who argued the states were acting.